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Abstract: Depending on the linker length between the VH and the VL domain, single-chain Fv
(scFv) antibody fragments form monomers, dimers (diabodies) or higher oligomers. We aimed at
generating a diabody of the anti-MET antibody 3H3 to use it as crystallization chaperone to promote
crystallization of the MET ectodomain through the introduction of a pre-formed twofold axis of
symmetry. Size exclusion chromatography, however, suggested the protein to be monomeric. Hence,
we used scattering techniques applied to solutions to further investigate its oligomerization state.
The small angle X-ray scattering (SAXS) curve measured for our protein nicely fits to the scattering
curve calculated from the known crystal structure of a diabody. In addition, concentration-dependent
photon correlation spectroscopy (PCS) measurements revealed a hydrodynamic radius of 3.4 nm
at infinite dilution and a negative interaction parameter kD, indicating attractive interactions that
are beneficial for crystallization. Both SAXS and PCS measurements clearly suggest our antibody
fragment to be a diabody in solution. Chemical cross-linking with glutaraldehyde and cell motility
assays confirmed this conclusion.
Keywords: DLS; SAXS; SLS; Zimm-Plot; IgG; antibody contstruct
1. Introduction
Antibodies belong to the most variable proteins of higher organisms. This variability is necessary
to recognize a vast number of different pathogens or foreign molecules and to trigger an adequate
immune response. There are five different classes of human antibodies (IgA, IgD, IgE, IgG, IgM) with
specific tasks [1,2]. IgG is the most abundant antibody in the blood serum and is used for therapeutical
purposes. Its overall structure resembles a Y shape with one fragment crystallizable (Fc) and two
antigen binding fragments (Fab). The Fc part is responsible for the stability of the antibody and for the
recruitment of effector molecules. The antigen binding sites are located at the ends of the Fab arms, in
the variable region of the heavy (VH) and the light chains (VL) [3,4].
Antibodies feature highly specific binding to a wide range of antigens. Therefore, antibodies are being
increasingly used for therapeutical purposes, such as passive immunization [5,6], immunomodulation
Antibodies 2019, 8, 48; doi:10.3390/antib8040048 www.mdpi.com/journal/antibodies
Antibodies 2019, 8, 48 2 of 19
(e.g., as therapy for multiple sclerosis) [7,8], cancer therapy (e.g., Trastuzumab [9–11] or monomethyl
auristatin E [12]) or for medical imaging (e.g., immunoscintigraphy [13,14]). Besides the use of whole
antibodies, the application of antibody fragments is widely spread and provides further advantages
[15,16]. Antibody fragments can be produced easily by expression in E. coli and P. pastoris with high yields
[17,18]. These fragments can be modified more easily, used as building blocks in biochemical engineering
[19,20] and show good pharmaco–kinetic profiles due to their smaller size. They are advantageously
usable for drug targeting with the benefit of being capable of penetrating solid tumor tissue quickly as
well as showing a fast clearance rate out of the residual tissue [15,16].
The smallest engineered antibody fragment containing the parental specificity is the variable
fragment (Fv). This is composed of the variable region of the heavy (VH) and the light chains
(VL) [21,22]. Both of these chains can be connected by a linker of a few amino acids resulting in
a scFv (Figure 1).
IgG dscFv (Diabody)
Triabody
C C
Figure 1. Schematic drawing: immunoglobulin (IgG) including the variable domains, (VH) and (VL),
single-chain Fv (scFv), diabody, triabody [23].
Oligomers of scFv can be obtained by shortening the linker length. A length of less than twelve
amino acids leads mainly to the formation of dimers (diabodies), while less then four amino acids
results in tri- and tetramers (tria- and tetrabodies) [24–26]. Due to the shorter linker length, no
binding is possible between the VH and VL domains of one chain, therefore the VH and VL domains
of different chains bind to each other forming oligomers [27–29]. Usually there is a strict separation
between the formation of different oligomers. Varying the linker length by only one amino acid may
shift the equilibrium completely to another oligomeric state with the lowest complexity being most
favourable [26].
So far, about 17 crystal structures of diabodies are known [30,31] and several of them use the same
base structure. Some of these strutures are of interest in the context of the present work (e.g., [27,32,33]).
These show that the two antigen binding sites are located at opposite sides of the protein. Therefore,
diabodies are able to bind two antigens or even two different epitopes of the same antigen. This means
they are bivalent molecules with a higher avidity than monomeric antibody fragments.
These two binding sites can also be beneficial for crystallization, because of the resulting twofold
symmetry [34]. However, according to Kwon et al. diabodies exhibit an important diversity and
flexibilty with respect to the orientation of the two scFv units [31]. The diabody (3H3) described in
this article binds to the MET receptor, a receptor for tyrosine kinase often involved in the formation of
tumors [35] and could therefore be used in cancer therapy. Moreover, the 3H3 diabody might act as
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crystallization chaperone [36] for the extracellular domain of MET, which has not yet been crystallized
in its entirety [37]. However, during the purification, contradictory results about the size of 3H3 were
obtained, which indicated that the protein might not be a diabody but rather a scFv, and therefore not
suitable for generating the desired twofold symmetry. Another possible explanation for the unexpected
size exclusion chromatography (SEC) results might be a strong interaction between the column and
the diabody. Hence, to analyze the oligomeric state in solution, different scattering methods were
employed to determine the size, shape, molecular mass and hydrodynamic properties of the protein.
The used combination of different scattering experiments might be of general interest, since processes
such as dimer or oligomer formation can be found for several proteins and oligomers might not stand
separation on SEC columns. Other proteins are intriniscally polydisperse like e.g., α-crystallin [38]
or might show major structural changes during activation which are not easy to capture by high
resolution methods but can be detected in-situ by low resolution approaches as presented here [39,40].
2. Materials and Methods
2.1. Protein Expression and Purification
P. pastoris was stably transfected with the desired target gene and the protein was expressed for
five days in minimal medium [41]. The expression was induced by a constant methanol level of 1%.
The supernatant was filtered, reduced by cross-flow filtration (membrane: Minimate TFF Capsule,
Omega 10 kDa; Pall Corporation, Port Washington, New York) and the buffer was exchanged against
phosphate buffered saline (PBS). The protein was then purified by Ni2+-NTA affinity chromatography
followed by dialysis against the low-salt buffer for ion exchange (IEX) chromatography (50 mM
Na-acetate, pH 4.7, 20 mM NaCl). IEX (Source 15S, GE Healthcare, Berlin, Germany) and finally
SEC with a HiLoad 16/60 Superdex 75 PG column (GE Healthcare, Berlin, Germany) equilibrated in
20 mM MES, pH 6.5, 150 mM NaCl buffer was used to obtain highly pure protein. The peak fractions
of the SEC excluding the long tail were pooled and concentrated to 10 mg ·mL−1 using Vivaspin
ultrafiltration devices. All solution scattering experiments were carried out in 20 mM MES, pH 6.5,
150 mM NaCl with protein diluted from this 10 mg ·mL−1 stock solution.
2.2. Analytical Size Exclusion Chromatography
A Superdex 75 10/300 GL (GE Healthcare, Berlin, Germany) column was equilibrated with
1.3 column volumes of 20 mM MES, pH 6.5, 500 mM NaCl buffer. After injecting the sample, the
protein was eluted using 1.3 column volumes during which the UV-absorbance at 280 nm was recorded.
The column was calibrated with ferritin (443 kDa, void volume) albumin (66 kDa), ovalbumin (43 kDa),
carbonic anhydrase (29 kDa), cytochrome C (12.4 kDa) and aprotinin (6.5 kDa) in PBS right before
running the 3H3 concentration range without changing the tubing between column and HPLC system
between these runs.
2.3. Cell Motility Assay
The ovarian cancer cell line SKOV-3 was grown in RPMI 1640 Glutamax medium (Life
Technologies, Monza, Italy), supplemented with antibiotics and 10% (v/v) fetal bovine serum (Life
Technologies). The cell migration assay was performed using a modified Boyden chamber assay (AC96
Migration Chamber; Neuro Probe, Gaithersburg, MD 20877, USA) with a porous membrane (8 µm,
PVP-free) previously coated with 100 µg ·mL−1 Collagen (Purecol, Cellsystems, Troisdorf, Germany)
in phosphate buffer saline. Cells were seeded in the top part of the chamber at a density of 106 mL−1
resuspended in serum-free RPMI 1640 with 0.25% (w/v) bovine albumin. 3H3 antibody molecules and
HGF/SF were plated in the bottom part of the chamber at selected concentrations. Cell migration was
carried on for six hours at 37 ◦C in a 5 % CO2 incubator. After that, the apparatus was disassembled and
non-migrated cells on the filter were gently removed by wiping the surface with cotton balls. Migrated
cells on the filter were fixed for one hour in 4% formaldehyde and stained for 30 min with DeepRed
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HCS Cell Mask Stain (Life Technologies) at 1 µg ·mL−1. Fluorescence intensity was measured using
the plate reader Odyssey (LI-COR Biosciences, Lincoln, Nebraska USA) using excitation at 700 nm.
Background fluorescence from non-stimulated cells was subtracted and the data shown are the mean
of triplicate sample [42].
2.4. Small-Angle X-ray Scattering
SAXS measurements were performed using a XEUSS system (XENOCS, Sassenage, France).
This provides monochromatic Cu Kα radiation and variable sample to detector distances between
50 cm and 277.5 cm. The setup consists of an evacuated collimation path with two variable scatterless
slits providing a beam of squared cross section (0.5 mm × 0.5 mm), an evacuated X-ray scattering path
and a hybrid-pixel area detector (Pilatus 300k, Dectris, Baden, Switzerland). The protein solutions
were placed in a quartz glass tube of 1 mm outer diameter and kept at room temperature. The total
measured scattering intensities were corrected by substraction of the scattering intensities of the buffer
filled tube and normalized with the time of measurement, the absorption and the concentration of
the sample. Glassy carbon was used to bring the data to the absolute scale [43].
For small angle scattering analysis the magnitude of the scattering vector q is, in general, given by
q =
4pin
λ
sin
(
θ
2
)
, (1)
with the refractive index of the medium n (1 in the case of X-ray scattering), the wavelength of the
incident beam λ and the scattering angle θ.
The scattering intensity I(q) detected by the detector consists of several factors:
I(q) =
N
V
∆b2P(q)S(q) = KSAXScMP(q)S(q). (2)
Here N/V is the number density of scatterers, ∆b = bProtein − bBuffer the excess scattering length
of the sample, P(q) the form factor representing the protein shape and S(q) the structure factor
representing intermolecular interactions. It is assumed that the samples are diluted in a way that
no intermolecular interactions occur and S(q) = 1. The scattering intensity is also dependent on the
concentration c of the sample, the molecular mass M and on the sample specific optical constant KSAXS.
KSAXS =
NA∆b2
M2
=
(ν∆ρ)2
NA
(3)
ν =
NAVProtein
M
. (4)
The optical constant KSAXS contains information about the specific volume ν of the protein and
the excess scattering length density ∆ρ = ρProtein − ρBuffer.
Guinier analysis was used as one common method for determining the radius of gyration Rg:
I(q) = I(0) exp
(
−1
3
R2gq
2
)
. (5)
2.5. Photon Correlation Spectroscopy
Photon correlation spectroscopy (PCS) is an established tool to study protein structure in
solution [39,44]. In a PCS experiment a digital correlator generates the intensity time correlation
function which is subsequently used to compute the electrical field time correlation function g1(t).
In the case of monodisperse samples g1(t) can be described by a single exponential function.
g1(t) = exp(−Γt). (6)
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The relaxation rate Γ is given by
Γ = Dexpq2, (7)
with the mutual translational diffusion coefficient Dexp.
However, real samples are polydisperse and might exhibit several relaxation modes stemming for
example from aggregates of different sizes. In this case g1(t) is given by
g1(t) =
∫ ∞
0
G(Γ) exp (−Γt)dΓ, (8)
with G(Γ) being the relaxation rate distribution. G(Γ) can be computed by an inverse Laplace
transformation.
For the determination of the z-averaged mutual diffusion coefficient 〈Dexp〉 the FORTRAN
program CONTIN provided by S. Provencher [45] was applied. 〈Dexp〉 can be related to the
hydrodynamic radius Rh of an equivalently diffusing sphere using the Stokes–Einstein equation [46]:
〈Dexp〉 = kBT
6piηRh
, (9)
with the temperature T, the Boltzmann constant kB, the viscosity of the solvent η. In the case of an
ideal infinitely diluted solution 〈Dexp〉 corresponds to the self-diffusion coefficient D0.
A further parameter which can be obtained from dynamic light scattering experiments is the
interaction parameter (dynamical virial coefficient) kD according to:
〈Dexp〉 = D0 (1 + kDc) . (10)
A positive kD points to repulsive intermolecular interactions, whereas a negative kD indicates
attractive interactions [47].
The PCS measurements were performed at two scattering angles, 60◦ and 135◦, and with nine
different sample concentrations in the range of 2.5 mg·mL−1 to 10 mg·mL−1. The samples with the
highest and the lowest concentrations were additionally measured angular dependent in steps of 10◦.
All samples were prepared directly before the measurements in a laminar flow workbench,
centrifuged for 15 min at 21,000 × g at 4 ◦C, filtered through a 0.2 µm syringe filter (Cellulose Acetate,
VWR International GmbH, Darmstadt, Germany) directly into a cylindrical quartz cuvette (540.110-QS,
Hellma GmbH and Co. KG, Darmstadt, Germany) and finally centrifuged for 5 min at 2000× g for the
removal of dust and air bubbles. The cuvettes were previously cleaned with freshly distilled acetone.
All PCS measurements were performed on a 3D photon cross correlation spectroscopy system from LS
Instruments (LS Instruments AG, Fribourg, Switzerland).
2.6. Static Light Scattering
The 3D photon cross correlation spectroscopy system from LS Instruments in addition was used
for statc light scattering experiments. This setup allows the measurement of the scattered intensity in
an angular range between 40◦ to 130◦. To obtain the scattering information of the pure sample on an
absolute scale and free of influences caused by the setup—called excess Rayleigh ratio Rex—the raw
intensity recorded by the detector Iraw has to be corrected angular dependent (ILaser: intensity of the
incoming beam, Iscattered: corrected scattered intensity) :
Iscattered =
(
Iraw · sin θ
ILaser
)
, (11)
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and a normalization with a standard, normally toluene, with a known Rayleigh ratio (scattering
intensity on absolute scale) Rref must be done as described in Equation (12) [48,49]:
Rex =
(
Is − Ib
Iref
)(
nb
nref
)2
Rref, (12)
with the scattered intensity of the sample Is, the buffer Ib and the reference Iref, the refractive index of
the solvent nb and of the reference nref.
2.7. Molecular Mass Determination with SLS—The Zimm-Plot
The data obtained by the static light scattering experiments [50] were evaluated with the Zimm
Equation (13).
This equation relates the form factor P(θ) to the optical constant K, the mass concentration c, the
molecular mass M and the second osmotic virial coefficient A2.
Kc
Rex
= P(θ)−1
(
1
M
+ 2A2c
)
. (13)
When using the Guinier approximation and a simplification, Equation (13) can be written as:
Kc
Rex
=
1
M
(
1 +
q2
3
〈
R2g
〉)
+ 2A2c, (14)
with
K =
4pi2 · n2
NA · λ40
·
(
dn
dc
)2
, (15)
containing the radius of gyration
〈
Rg
〉
, the Avogadro constant NA, the wavelength of the light in
vacuo λ0 and the refractive index increment dn/dc.
For the construction of the Zimm diagram KcRex is plotted against q
2 + kc and an extrapolation
to q = 0 and c = 0 is done. On the basis of these extrapolations the molecular mass, the second
virial coefficient, the radius of gyration is yielded. The scaling factor k only influences the appearance
of the plot. Hence, the Zimm equation and the plot consolidate all experimental and molecular
parameters of the static light scattering experiment.
All measurements were done at 20 ◦C and the scattered intensities of the samples were recorded
in the scattering angle range between 40◦ and 130◦ in steps of 1◦. For the measurements of the
buffer solution and the toluene reference the same parameters were used. All samples were prepared
analogously to those used in PCS measurements.
2.8. Density, Refractive Index and Refractive Index Increment Measurement
The density and the refractive index measurements were performed on a DMA 4500 density meter
and on an RXA 170 refractometer from Anton Paar (Graz, Austria). All measurements were repeated
at least three times and the averaged values were taken for further calculations. The refractive index
increment was determined using the α-Ref.-System (Version 2.1) from SLS-Systemtechnik (Denzlingen,
Germany) with a quartz cuvette (410.45, Starna GmbH, Pfungstadt, Germany). All measurements
were performed at 20 ◦C.
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2.9. Molecular Mass Calculation from SAXS Data
Determining the molecular mass was an important step to be able to identify the degree of
oligomerization of the protein. The molecular mass can be determined using scattering data on
absolute scale by extrapolation to I(0) [51] and using the following formula [52]:
MProt =
I(0)absNA
cProt(∆ρν)2
. (16)
Another approach is to compare the scattering data of the sample with the scattering data of a
standard [53] e.g., lysozyme. The molecular mass can then be determined by :
MProt =
I(0)Prot
cProt
MLys
I(0)Lys/cLys
. (17)
2.10. Prediction and Evaluation of a Possible Structure Model
To obtain a first idea of what kind of oligomer the 3H3 forms, we simulated the scattering curves
of an scFv (1X9Q [54]), a diabody (1LMK [27]) and a triabody (1NQB [55]). For this purpose known
crystal structures of homologous proteins from the RCSB protein data bank (PDB) were used and
their scattering intensities were calculated using the software CRYSOL [56] from the ATSAS software
package. With the best fitting structure from the CRYSOL calculation hydrodynamic calculations were
performed with the program HYDROPRO [57–60]. HYDROPRO allows to compute the theoretical
diffusion coefficient of proteins based on a structural model [61,62].
3. Results and Discussion
3.1. SEC Analysis
During purification of our 3H3 construct there were hints that it might not form a diabody.
The protein eluted with a main peak corresponding to a molecular mass of around 33 kDa from a
preparative SEC run at high protein concentration (10 mg·mL−1) but low salt concentration (20 mM
NaCl) (Figure S1A, see Supporting Information). The long tail was not due to protein degradation as
shown by a SDS-PAGE analysis (Figure S1B), possibly indicating protein adsorption to the column
matrix. We analyzed the oligomeric state of the protein further by analytical SEC. At low protein
concentration there was no elution peak at low and physiological salt concentrations (20 mM and
150 mM NaCl) again indicating potential adsorption of the protein to the column matrix, while at
higher salt concentrations (500 mM and 1 M NaCl) peaks of increasing height appeared at a constant
elution volume (data not shown). We performed SEC runs at 500 mM NaCl covering a 500-fold range
of protein concentrations, reaching from the detection limit of our UV detector (20 µg·mL−1) to the
highest protein concentration that we could afford (10 mg·mL−1). The elution volume stayed constant
over the whole concentration range and corresponded to a molecular mass of 41 kDa (Figure 2). This is
in between the calculated molecular mass of the scFv (27 kDa) and that of the diabody (54 kDa). Only
an elution volume larger than expected can be explained fairly easily by a non-globular shape of the
sample. Based on the SEC results one might, therefore, conclude that no diabody is formed. However,
crosslinking experiments indicated that the 3H3 is a dimeric protein (see Figure S2 in the Supporting
Information).
Some single-chain Fvs show a dynamic, concentration-dependent equilibrium between monomer
and dimer. In one report, two well-separated peaks corresponding to the monomer and the dimer
(diabody) were observed in SEC runs with the scFv MFE-23 [63]. At low protein concentration
(0.5 mg·mL−1) the dimer peak was barely visible, while at 10 mg·mL−1 the dimer peak almost reached
the same height as the monomer peak. We did not observe such a double peak on SEC over a 25-fold
wider concentration range (20 µg·mL−1–10 mg·mL−1) suggesting that the unusual elution behavior of
the 3H3 diabody is caused by an interaction between the protein and the SEC matrix. It also seems
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unlikely that our 3H3 diabody could form a monomeric scFv because of its short linker length. Our
3H3 diabody contains a four-residue Gly4 linker, while the MFE-23 scFv that showed reversible dimer
formation had a 15-residue (Gly4Ser)3 linker [63]. In addition, we also prepared a covalently linked
dimer of two Fab fragments from 3H3 by digesting the intact antibody with pepsin. This F(ab’)2
fragment eluted from a Superose 12 10/300 column as a single, monomeric peak with a calculated
molecular weight of about 60 kDa (data not shown), which again is closer to the molecular weight
of a monomeric Fab fragment (50 kDa) than to the actual molecular weight of the dimeric F(ab’)2
fragment (100 kDa). Due to the covalent linkage of the two Fab fragments via a disulfide bridge,
a monomer–dimer equilibrium cannot be at play here. In this case the bead chemistry of the column is
somewhat different from the Superdex matrix used in our other experiments. Hence, SEC on 3H3 and
its fragments seems to lead to unexpected results.
To resolve the discrepancy we used solution scattering methods to investigate the protein in
its native state. The combination of PCS and SAXS provides complementary information on the
overall size, the molecular mass and the low resolution structure of proteins.
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Figure 2. Analytical size exclusion chromatography of 3H3. A Superdex 75 10/300 column was
equilibrated with 20 mM MES, pH 6.5, 500 mM NaCl. Four runs with 100 µL of 3H3 at the indicated
protein concentrations were performed. The absorbance at 280 nm (A280) is shown with a separately
scaled y-axis for each concentration so that the baselines are slightly offset and the maxima coincide,
thus allowing accurate comparison of elution volumes and peak profiles. The elution volume of
standard proteins in a dedicated calibration run is indicated by arrows at the top. The void volume
was determined with ferritin (443 kDa). The expected elution volume (Ve) for the diabody (54 kDa)
and the scFv (27 kDa) were calculated based on the calibration and are indicated with red and gray
arrows, respectively.
3.2. SAXS Data Analysis
SAXS measurements were performed with sample concentrations of 2.5 mg·mL−1, 5 mg·mL−1
and 10 mg·mL−1 at three sample-to-detector distances to cover a possible q-range from 0.04 nm−1 to
6.78 nm−1. Figure 3 shows a Kratky-plot of the experimental data.
For the lowest 3H3 concentration the data at high q are rather noisy. However, for the higher
concentrations the typical scattering pattern for a multidomain protein is observed.
The usable q-range after buffer subtraction ranges from 0.18 nm−1 to 1.67 nm−1 (Figure 4B).
The plot of the concentration normalized data shows no major difference in the scattering intensities in
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the q-region between 0.3 nm−1 and 1 nm−1. Therefore a significant concentration dependent change of
the shape can be ruled out. The decrease in intensity of the concentration normalized scattering curves
at low q-values with increasing sample concentration can be explained by the contribution of the
structure factor, which at least at 10 mg·mL−1 does not strictly follow S(q) ≈ 1. The PCS experiments
which are discussed in Section 3.4 indicate attractive interaction. According to Tardieu et al. [64]
this would mean S(q = 0) > 1. The shape of the black curve in Figure 4B might also indicate this.
However, the influence of S(q) is only marginal in the scrutinized q-range.
Figure 3. Kratky-plot of the calibrated SAXS data over the total measured q-range. For the
lowest concentration (2.5 mg·mL−1) the data are rather noisy, especially at high q. However, for
3H3 concentrations 5 mg·mL−1 and 10 mg·mL−1 a shoulder is obsered in the plots indicating the
multidomain character of the protein in solution. This is the expected pattern for a diabody.
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Figure 4. (A) p(r)—functions obtained by GNOM and (B) the corresponding fit in the reciprocal space
(for clarity, the upper two data sets have been shifted by a factor of 10 and 100, respectively).
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The structural parameters and the molecular mass of the 3H3 antibody fragment derived from
these curves are given in Table 1. The radius of gyration Rg estimated by the Guinier approximation
Equation (5) is 3.36(9) nm. The GNOM calculation yields Rg = 3.06 nm. GNOM was also used to
calculate the pair distance distribution function p(r) (Figure 4A).
Table 1. Structural parameters derived from experimental SAXS data. Here, Rg indicates the radii of
gyration as computed by a Guinier and GNOM analysis, respectively. Dmax is the maximum dimension
of the 3H3 diabody is obtained from the p(r) functions. M(lys) is the molecular mass as obtained from
the SAXS data using lysozyme as a standard.
Parameter Experiment 1LMK
10 mg·mL−1 5 mg·mL−1 2.5 mg·mL−1
Rg (Guinier)/nm 3.66 3.29 3.27 2.9Rg (GNOM)/nm 3.24 3.04 2.89
Dmax/nm 9.4 9.02 8.50
M(lys)/kDa 46.8 43.4 49.3
For better comparison in Figure 5 the SAXS data are normalized to the different protein
concentration. In addition, also the respective GNOM fits are shown.
Figure 5. SAXS data normalized to concentration with the respective GNOM fits. The discrepancies
between the curves can be attributed to increased interaction between the 3H3 molecules at higher
concentration. These differences lead to a variation in the obtained apparent radius of gyration Rg of
about ±5 to 6%.
The differences in the curves can be attributed to stronger interaction at higher concentration and
lead to minor differences between the computed Rg values. However, for the conclusions derived later
on, the differences are not relevant.
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The molecular mass of the protein can be determined from the scattering data in several ways.
By extrapolation to I(0) a mean molecular mass of 70.8 kDa was obtained. The comparison with
lysozyme as standard resulted in a mean molecular mass of 46.5 kDa (Table 1). Compared to the
calculated molecular mass of the diabody of 53.9 kDa the results deviate in the range of 9 % to 41 %,
compared to the molecular mass of the scFv with 26.95 kDa the deviation is much higher (61 % to
183 %). The molecular mass determination by SAXS leads to the assumption that 3H3 is actually
a dimer. To reinforce this result, simulations were done.
3.3. Calculation of SAXS Data with CRYSOL
To verify the conclusion based on the different determinations of the molecular mass and to reveal
the structure of 3H3 in solution in an independent way, the theoretical scattering curves of the different
possible oligomers were calculated by CRYSOL [56] and compared with the experimental data. The
calculations were based on a choice of crystal structures of homologous proteins listed in the PDB.
Coordinates from PDB entries 1X9Q [54], 1LMK [27] and 1NQB [55] were used to calculate theoretical
scattering curves of a monomeric scFv, a diabody and a triabody, respectively (Figure 6). Figure 6
shows the experimental data for the 3H3 protein solution at a concentration of 5 mg·mL−1 and the
results from the simulated scattering curves. The calculated curve of the diabody structure nicely
fit to the measured data, whereas both of the other curves show large deviations. Hence, the model
calculations clearly show that 3H3 forms a diabody in solution.
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Figure 6. (A) Comparison of simulated scattering patterns of a monomeric scFv, a diabody and a
triabody computed with CRYSOL to experimental data. (B) Comparison of theoretically calculated
scattering paterns of several different diabodies with the experimental data. The scattering patterns of
the different diabodies were obtained using the PDB entries and CRYSOL. The shown experimental
data were obtained for the sample with a concentration of 5 mg·mL−1.
As a next step, the experimental scattering patterns were compared with the calculated scattering
data of diabody structures from the PDB (1LMK, 1MOE, 4Y5X, 4Y5Y) to identify the structurally most
similar model for 3H3. Figure 6 shows that all the calculated curves almost fit to the measured data.
The calculated scattering data of 1LMK matches the experimental data best with a chi2-value of 1.60.
3.4. Photon Correlation Spectroscopy (PCS) Data
PCS provides another independent way to determine protein structures in solution in a rather
fast and easy way. For the determination of the hydrodynamic properties of the 3H3 diabody
photon correlation spectroscopy measurements were performed at different sample concentrations
and two scattering angles. For two concentrations (the lowest and the highest) angular-dependent
measurements were performed. The obtained data were analyzed using CONTIN. The relaxation
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rate distribution shows one sharp peak and at lower angles a broad contribution which indicates
a small amount of aggregates. Plotting the relaxation rate of the main mode against the squared
scattering vector (Figure 7) leads to the translational diffusion coefficient Dexp (Table 2) according
to Equation (7). The interaction parameter kD is given by the slope of a concentration-dependent
plot of the translational diffusion coefficient (Equation (10); data not shown) and is determined to
−1.50× 10−2 mg·mL−1 from the measurements at a scattering angle of 60◦. Negative values stand
for attractive intermolecular interactions between protein molecules in the given solvent [47], which
denotes a good precondition for crystallization. Analyzing the translational diffusion coefficient
regarding the measurements at different sample concentrations, the extrapolation to zero concentration
results in the self diffusion coefficient D0 = 6.295× 10−11 m2·s−1 and the associated Rh,0 = 3.4 nm.
The self diffusion coefficient describes the diffusion behaviour of a single molecule.
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Figure 7. Plots of the relaxation rate Γ vs. q2 for 2.5 mg·mL−1 and 10 mg·mL−1. The slope yields the
translational diffusion coefficient (see Table 2). Within the experimental precision the intercept is zero,
as expected for the simple center of mass diffusion.
Table 2. Hydrodynamic parameters measured by photon correlation spectroscopy (PCS) (PCS is often
also called DLS (dynamic light scattering). Dexp is the experimentally found translational diffusion
coefficent as obtained from a numerical analysis of the PCS data. The hydrodynamic radius Rh is
computed on the basis of Dexp (see the Materials and Methods section).
Parameter 2.5 mg·mL−1 10 mg·mL−1
Dexp/nm2·s−1 5.95 × 107 5.06 × 107
Rh,exp/nm 3.60 4.24
3.5. Calculation of Hydrodynamic Data with HYDROPRO
In a further evaluation step the hydrodynamic properties of the scFv structure 1X9Q and of the
similar diabody 1LMK were calculated using the software HYDROPRO [57–60]. The temperature,
the solvent viscosity η and density ρ, the partial specific volume ν and the molecular mass M were
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set to the values in Table 3, for the other parameters default values of HYDROPRO were used.
The hydrodynamic radius was calculated from the results using Equation (9).
Table 3. Calculated hydrodynamic properties, Relement consists of 2.9 Å (recommended by the software)
for one element and 3 Å for the first hydration shell, the calculation is based on the: atomic level primary
model, shell calculation (type 1). The listed experimental values are extrapolations for infinite dilution.
Here, ν is the specific average volume of a protein, ρ and η are the density and the viscosity of the buffer.
1X9Q (scFv) 1LMK (Diabody) Experiment
Relement/Å 5.9 5.9 -
Type of calculation 1 1 -
T / ◦C 20 20 20
η/mPa s 101.6 101.6 101.6
M/kDa 29.447 53.911 -
ν/cm3 g−1 0.725 0.731 -
ρ/g cm−3 1.00677 1.00677 -
D0, theo/m2·s−1 7.74 × 10−11 5.94 × 10−11 6.295 × 10−11
Rg, theo/nm 2.1 2.9 -
Rh,0, theo/nm 2.8 3.6 3.4
Rg, theo/Rh, theo 0.75 0.81 -
D0 calculated for the structural model of a diabody was 5.94× 10−11 m2·s−1. Hence, within the
experimental error an excellent agreement between the PCS experiment and the model calculation of
this diabody is obtained.
3.6. Zimm Analysis
In addition to the determination of hydrodynamic properties using photon correlation
spectroscopy, static light scattering in combination with the Zimm analysis was used to obtain the
molecular mass. The basis for this analysis was the data obtained from angular dependent static
light scattering measurements of samples with five different protein concentrations. The formalism is
based on the assumption of linear dependence of the intensity on concentration and q, respectively.
This approach allows us to determine the molar mass and other parameters at zero protein
concentration [49]. In a broad range of scattering angles and concentrations the experimental
data showed the expected linear behavior and consequently the Zimm formalism can be applied
to these linear regions. In Figure 8 the results with a linear fit and the extrapolation according
to the Equations (13) and (14). The intercept of both extrapolated lines with the y-axis is at
2.0666× 10−5 mol·g−1. Thus, the resulting molecular mass obtained by static light scattering is
48.4 kDa (data listed in Table 4. This is in very good accordance with the sequence based molecular mass
of 53.9 kDa of the 3H3 diabody. Moreover, this rules out any significant contribution from unimers.
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Table 4. Parameters used for the Zimm-analysis. The listed parameters are input values for the analysis
and are defined in the Materials and Methods section. The given refractive index increment dn/dc
results from measurements on our 3H3 samples and is about 25 % larger compared to values reported
in the literature [65].
Parameter Value
c/mg·mL−1 0.91, 2.58, 4.9, 7.71, 10.0
Rex, Toluene/cm−1 13.43× 10−6
dn/dc/cm3 g−1 0.267
nb, MES-Buffer 1.335
nref, Toluene 1.496
k/nm·g−1 10
K/mol (m/g)2 5.550 38× 10−11
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Figure 8. The Zimm-diagram obtained from the static light scattering measurements (black: measured
data, orange: extrapolation to q = 0, green: extrapolation to c = 0, lines: linear fits).
3.7. Cell Motility Assay
The scattering experiments were performed at relatively high protein concentrations of 1 to
10 mg/mL. We used a sensitive cell motility assay to obtain hints about the oligomeric state of the 3H3
diabody at very low protein concentration. Cell motility is a result of MET activation, which in turn
is a caused by MET dimerization. The endogenous MET ligand HGF/SF served as positive control
and stimulated migration of SKOV-3 cells at a concentration as low as 100 pM (Figure 9). The 3H3
diabody showed a bell-shaped dose-response curve very similar to that of the intact 3H3 antibody
(Figure 9). Both showed maximal activity at 3 nM (160 ng·mL−1), while at 100 nM no stimulation of cell
migration was observed. The 3H3 diabody was active down to a concentration of 300 pM (16 ng·mL−1).
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This strongly suggests that our 3H3 construct is bivalent like the intact 3H3 IgG molecule and thus is
dimeric even at low concentration.
Figure 9. Cell motility assay (migration of SKOV-3 cells). A modified Boyden chamber assay was used
to analyze stimulation of cell motility in SKOV-3 cells. HGF/SF served as positive control and showed
the typical bell-shaped dose-response curve with activity down to 100 pM. The intact 3H3 antibody
(3H3-IgG) and the 3H3 diabody (3H3-dscFv) also showed a bell-shaped dose-response curve. The
diabody stimulated cell migration down to a concentration of 100 pM.
4. Conclusions
In this work we have studied the solution structure of the IgG fragment 3H3. Contrary to the
results obtained by SEC, indicating the presence of only unimers in solution, it could be clearly shown
by non-invasive low resolution scattering experiments that in fact predominantly diabodies are formed
in solution. This assumption is supported by the Zimm analysis of 3H3 that at infinite dilution
yielded a hydrodynamic radius in good accordance with the predicted molecular mass of the diabody
(see Section 3.6). Using the structure of 1LMK as a model for a diabody in hydrodynamic model
calculations based on the methods introduced by Garcia de la Torre, we calculated a translational
diffusion coefficient of 5.94× 10−11 m2·s−1. This is in good agreement with the experimental value of
D0 = 6.295× 10−11 m2·s−1. In conclusion, our experiments convincingly show 3H3 can produce the
desired twofold symmetry that is beneficial for crystallization. Finally, the bell-shaped dose-response
curve in the cell motility assay strongly suggests that our 3H3 construct actually forms a bivalent
diabody able to dimerize MET at a concentration as low as 1 nM (≈50 ng mL−1). Hence, trying
to use the 3H3 diabody as a crystallization chaperone in complex with the MET receptor seems a
promising approach.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4468/8/4/48/s1,
Figure S1: Preparative size exclusion chromatography of the 3H3 diabody; Figure S2: Analysis of chemical
crosslinking with glutaraldehyde; Figure S3: Distribution of the relaxation rates as computed by a CONTIN
analysis. In the respective photon correlation spectroscopy experiment a 3H3 solution with a concentration of
10 mg·mL−1 was measured at two scattering angles (60◦ (A); 100◦ (B)); Figure S4: Distribution of the relaxation
rates as computed by a CONTIN analysis. In the respective photon correlation spectroscopy experiment a 3H3
solution with a concentration of 2.5 mg·mL−1 was measured at two scattering angles (60◦ (A); 100◦ (B)).
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